Skip to main content

letter

. 1984 May;59(5):489–490. doi: 10.1136/adc.59.5.489

Prophylactic ethamsylate for periventricular haemorrhage.

L M Dubowitz, A Whitelaw

PMCID: PMC1628516 PMID: 6732284

489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cooke R. W., Morgan M. E. Prophylactic ethamsylate for periventricular haemorrhage. Arch Dis Child. 1984 Jan;59(1):82–83. doi: 10.1136/adc.59.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
Donn S. M., Roloff D. W., Goldstein G. W. Prevention of intraventricular haemorrhage in preterm infants by phenobarbitone. A controlled trial. Lancet. 1981 Aug 1;2(8240):215–217. doi: 10.1016/s0140-6736(81)90470-0. [DOI] [PubMed] [Google Scholar]
Morgan M. E., Benson J. W., Cooke R. W. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies. Lancet. 1981 Oct 17;2(8251):830–831. doi: 10.1016/s0140-6736(81)91103-x. [DOI] [PubMed] [Google Scholar]
Whitelaw A., Placzek M., Dubowitz L., Lary S., Levene M. Phenobarbitone for prevention of periventricular haemorrhage in very low birth-weight infants. A randomised double-blind trial. Lancet. 1983 Nov 19;2(8360):1168–1170. doi: 10.1016/s0140-6736(83)91217-5. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES